Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132150) titled 'Efficacy and Safety Evaluation of Perfluorohexyloctane Eye Drops in the Treatment of Post-LASIK dry eye disease: A Prospective, Parallel-Group, Randomized Controlled Trial' on Sept. 10.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: DaLian He Eye Hospital.Co.Ltd

Condition: Dry eye disease

Intervention: Perfluorohexyloctane combined with 0.2% Hylo-Comod? in the experimental group:Perfluorohexyloctane ophthalmic solution

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-12-01

Target Sample Size: Perfluorohexyloctane combined with 0.2% Hylo-Comod? in...